Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Suppression of type 17 immunity by type I interferon (IFN) during influenza A infection has been shown to enhance susceptibility to secondary bacterial pneumonia. Although this mechanism has been described in coinfection with gram-positive bacteria, it is unclear whether similar mechanisms may impair lung defense against gram-negative infections. Furthermore, precise delineation of the duration of type I IFN-associated susceptibility to bacterial infection remains underexplored. Therefore, we investigated the effects of preceding influenza A virus infection on subsequent challenge with the gram-negative bacteria Escherichia coli or Pseudomonas aeruginosa and the temporal association between IFN expression with susceptibility to Staphylococcus aureus challenge in a mouse model of influenza and bacterial coinfection. Here we demonstrate that preceding influenza A virus led to increased lung E. coli and P. aeruginosa bacterial burden, which was associated with suppression of type 17 immunity and attenuation of antimicrobial peptide expression. Enhanced susceptibility to S. aureus coinfection ceased at day 14 of influenza infection, when influenza-associated type I IFN levels had returned to baseline levels, further suggesting a key role for type I IFN in coinfection pathogenesis. These findings further implicate type I IFN-associated suppression of type 17 immunity and antimicrobial peptide production as a conserved mechanism for enhanced susceptibility to both gram-positive and gram-negative bacterial coinfection during influenza infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 2×
“During the 1918 344 influenza pandemic, up to three quarters of influenza-associated deaths involved coinfection 345 with Streptococcus or Staphylococcus species (32).”
BackgroundGoetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355 · cited 1×
“35, 44), where LCN2 exerts bacteriostatic activity via interference of siderophore-mediated 324 bacterial iron acquisition (17).”
BackgroundInsights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Sun, K., & Metzger, D. W. (2008) · Nature Medicine · doi:10.1038/nm1765 · Cited by 587
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
McCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423 · cited 3×
“Since the majority of coinfection studies in the mouse 247 model have focused on Gram-positive bacterial infection three to seven days following IAV 248 infection (22-25, 30, 31, 34, 35, 38, 39), we again returned to the IAV, S.”
BackgroundMethodInfluenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.
Kudva, A., Scheller, E. V., Robinson, K. M., Crowe, C. R., Choi, S. M., Slight, S. R., Khader, S. A., Dubin, P. J., Enelow, R. I., Kolls, J. K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002194 · Cited by 346 · cited 7×
“Discussion 274 These data demonstrate that preceding IAV infection impairs the host response to 275 bacterial challenge with Gram-negative bacteria, similar to the attenuation previously described 276 during IAV and Gram-positive bacterial coinfection (23, 25).”
BackgroundMethodResultInfluentialSelf-citationFinelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312
McNamee, L. A., & Harmsen, A. G. (2006) · Infection and Immunity · doi:10.1128/iai.00789-06 · Cited by 233
Influenza virus primes mice for pneumonia from Staphylococcus aureus.
Iverson, A. R., Boyd, K. L., McAuley, J. L., Plano, L. R., Hart, M. E., & McCullers, J. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq113 · Cited by 168
Influenza A Exacerbates Staphylococcus aureus Pneumonia by Attenuating IL-1β Production in Mice
Robinson, K. M., Choi, S. M., McHugh, K. J., Mandalapu, S., Enelow, R. I., Kolls, J. K., & Alcorn, J. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301237 · Cited by 126 · cited 3×
“Since the majority of coinfection studies in the mouse 247 model have focused on Gram-positive bacterial infection three to seven days following IAV 248 infection (22-25, 30, 31, 34, 35, 38, 39), we again returned to the IAV, S.”
BackgroundMethodResultPostinfluenza bacterial pneumonia: Host defenses gone awry
Ballinger, M. N., & Standiford, T. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0049 · Cited by 103
Lipocalin 2 is protective against E. coli pneumonia
Wu, H., Santoni-Rugiu, E., Ralfkiaer, E., Porse, B. T., Moser, C., Høiby, N., Borregaard, N., & Cowland, J. B. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-96 · Cited by 82
Muscedere, J., Ofner, M., Kumar, A., Long, J., Lamontagne, F., Cook, D., McGeer, A., Chant, C., Marshall, J., Jouvet, P., et al. (2013) · Chest · doi:10.1378/chest.12-1861 · Cited by 40 · cited 2×
“Recent data suggest that in patients 366 admitted to the intensive care unit for influenza, recovery of Gram-negative bacteria rises 367 substantially following admission (33).”
Background
Cited by
The Roles of Type I Interferon in Bacterial Infection
Boxx, G. M., & Cheng, G. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.016 · Cited by 335
Bacterial co‐infections with SARS‐CoV‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 291
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
Rynda-Apple, A., Robinson, K. M., & Alcorn, J. F. (2015) · Infection and Immunity · doi:10.1128/iai.00298-15 · Cited by 286
Self-citationBack to the Future: Lessons Learned From the 1918 Influenza Pandemic
Short, K. R., Kedzierska, K., & van de Sandt, C. E. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00343 · Cited by 278
Type I interferons in bacterial infections: A balancing act
Kovarik, P., Castiglia, V., Ivin, M., & Ebner, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00652 · Cited by 117
Metadata
- Authors
- Lee, B., Robinson, K. M., McHugh, K. J., Scheller, E. V., Mandalapu, S., Chen, C., Di, Y. P., Clay, M. E., Enelow, R. I., Dubin, P. J., & Alcorn, J. F.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2015-07-15
- Volume
- 309
- Issue
- 2
- Pages
- L158-L167
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W2301738150
- Cited by
- 135
- References
- 15
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.